Etoiles Capital Group Closes $6.44M Sale of Class A Ordinary Shares.
ByAinvest
Wednesday, Aug 13, 2025 11:32 am ET1min read
EFTY--
The additional shares were sold to underwriters, who exercised their over-allotment option granted during the IPO. This option allowed them to purchase up to 210,000 shares at the IPO price, less underwriting discounts. The total proceeds from the IPO and the additional sale amount to $6.44 million, which will be allocated towards business expansion, technology infrastructure, strategic marketing, and general corporate purposes [2].
The company's shares are now trading on the Nasdaq Capital Market under the ticker symbol "EFTY," enhancing its visibility and accessibility to a broader range of investors. Prime Number Capital, LLC acted as the underwriter for both the IPO and the additional share sale [1, 2].
References:
[1] https://www.quiverquant.com/news/Etoiles+Capital+Group+Co.%2C+Ltd+Completes+Successful+Initial+Public+Offering+on+Nasdaq
[2] https://www.globenewswire.com/news-release/2025/08/13/3132800/0/en/Etoiles-Capital-Group-Co-Ltd-Announces-Closing-of-Underwriters-Over-Allotment-Option-in-Connection-with-Initial-Public-Offering.html
Etoiles Capital Group Co., Ltd has closed the sale of 210,000 Class A ordinary shares at $4.00 per share, raising a total of $6,440,000. The proceeds will be used for business expansion, technology infrastructure, strategic marketing, and general corporate purposes. The offering was conducted on a firm commitment basis, with Prime Number Capital acting as the underwriter.
Etoiles Capital Group Co., Ltd has successfully closed the sale of an additional 210,000 Class A ordinary shares at a price of $4.00 per share, raising a total of $6.44 million. This sale, conducted on a firm commitment basis, follows the company's initial public offering (IPO) on August 11, 2025, where it raised $5.6 million by offering 1.4 million shares at the same price [1].The additional shares were sold to underwriters, who exercised their over-allotment option granted during the IPO. This option allowed them to purchase up to 210,000 shares at the IPO price, less underwriting discounts. The total proceeds from the IPO and the additional sale amount to $6.44 million, which will be allocated towards business expansion, technology infrastructure, strategic marketing, and general corporate purposes [2].
The company's shares are now trading on the Nasdaq Capital Market under the ticker symbol "EFTY," enhancing its visibility and accessibility to a broader range of investors. Prime Number Capital, LLC acted as the underwriter for both the IPO and the additional share sale [1, 2].
References:
[1] https://www.quiverquant.com/news/Etoiles+Capital+Group+Co.%2C+Ltd+Completes+Successful+Initial+Public+Offering+on+Nasdaq
[2] https://www.globenewswire.com/news-release/2025/08/13/3132800/0/en/Etoiles-Capital-Group-Co-Ltd-Announces-Closing-of-Underwriters-Over-Allotment-Option-in-Connection-with-Initial-Public-Offering.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet